Literature DB >> 15548699

P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells.

Joana Paredes1, Christophe Stove, Veronique Stove, Fernanda Milanezi, Veerle Van Marck, Lara Derycke, Marc Mareel, Marc Bracke, Fernando Schmitt.   

Abstract

P-cadherin expression in breast carcinomas has been associated with tumors of high histologic grade and lacking estrogen receptor-alpha, suggesting a link between these proteins. In the MCF-7/AZ breast cancer cell line, blocking estrogen receptor-alpha signaling with the antiestrogen ICI 182,780 induced an increase of P-cadherin, which coincided with induction of in vitro invasion. Retroviral transduction of MCF-7/AZ cells, as well as HEK 293T cells, showed the proinvasive activity of P-cadherin, which requires the juxtamembrane domain of its cytoplasmic tail. This study establishes a direct link between P-cadherin expression and the lack of estrogen receptor-alpha signaling in breast cancer cells and suggests a role for P-cadherin in invasion, through its interaction with proteins bound to the juxtamembrane domain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548699     DOI: 10.1158/0008-5472.CAN-04-0795

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

Review 1.  Involvement of members of the cadherin superfamily in cancer.

Authors:  Geert Berx; Frans van Roy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09-23       Impact factor: 10.005

Review 2.  Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer.

Authors:  Heather C Bruner; Patrick W B Derksen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

3.  P-cadherin expression and basal-like subtype in breast cancers.

Authors:  N Liu; Q Yu; T J Liu; Estifanos P Gebreamlak; S L Wang; R J Zhang; J Zhang; Y Niu
Journal:  Med Oncol       Date:  2012-04-01       Impact factor: 3.064

4.  P-cadherin counteracts myosin II-B function: implications in melanoma progression.

Authors:  Koen Jacobs; Mireille Van Gele; Ramses Forsyth; Lieve Brochez; Barbara Vanhoecke; Olivier De Wever; Marc Bracke
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

5.  Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer.

Authors:  Cunxi Li; Haiting Ma; Yang Wang; Zheng Cao; Ramona Graves-Deal; Anne E Powell; Alina Starchenko; Gregory D Ayers; Mary Kay Washington; Vidya Kamath; Keyur Desai; Michael J Gerdes; Lila Solnica-Krezel; Robert J Coffey
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

6.  P-cadherin and beta-catenin are useful prognostic markers in breast cancer patients; beta-catenin interacts with heat shock protein Hsp27.

Authors:  Mariel A Fanelli; Magdalena Montt-Guevara; Angela M Diblasi; Francisco E Gago; Olga Tello; F Darío Cuello-Carrión; Eduardo Callegari; Maria A Bausero; Daniel R Ciocca
Journal:  Cell Stress Chaperones       Date:  2008-03-05       Impact factor: 3.667

7.  Cadherin cell adhesion system in canine mammary cancer: a review.

Authors:  Adelina Gama; Fernando Schmitt
Journal:  Vet Med Int       Date:  2012-08-22

Review 8.  Vitamin D and the mammary gland: a review on its role in normal development and breast cancer.

Authors:  Nair Lopes; Joana Paredes; José Luis Costa; Bauke Ylstra; Fernando Schmitt
Journal:  Breast Cancer Res       Date:  2012-05-31       Impact factor: 6.466

9.  Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells.

Authors:  Hanne A Askautrud; Elisabet Gjernes; Gro L Størvold; Mona M Lindeberg; Jim Thorsen; Hans Prydz; Eirik Frengen
Journal:  BMC Biotechnol       Date:  2009-10-16       Impact factor: 2.563

10.  CCAAT/enhancer binding protein β (C/EBPβ) isoforms as transcriptional regulators of the pro-invasive CDH3/P-cadherin gene in human breast cancer cells.

Authors:  André Albergaria; Carlos Resende; Ana Rita Nobre; Ana Sofia Ribeiro; Bárbara Sousa; José Carlos Machado; Raquel Seruca; Joana Paredes; Fernando Schmitt
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.